Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Systemic administration of tiludronate or clodronate decreases lameness in some horses suffering from navicular syndrome within 2-6 months of treatment. In horses that fail to respond to the first treatment, a follow-up treatment may still improve the lameness. Horses with a lameness duration of les...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.15653/TPG-170804
データ提供:米国国立医学図書館(NLM)
Bisphosphonates: A Potential Solution for Navicular Syndrome in Horses
Imagine a horse, a magnificent creature, struggling with pain in its hooves. Navicular syndrome, a common condition in horses, can cause significant lameness. This study explores the use of bisphosphonates, a class of drugs that can help strengthen bones, as a potential treatment for navicular syndrome. The study reviews the existing research on the use of bisphosphonates in horses, examining both the benefits and potential risks associated with this treatment approach. The researchers found that bisphosphonates can be effective in reducing lameness in some horses with navicular syndrome, but they also highlight the importance of careful monitoring and consideration of potential side effects.
Bisphosphonates: A Promising Avenue for Treating Navicular Syndrome
This study provides a comprehensive overview of the use of bisphosphonates in horses, specifically focusing on their potential role in managing navicular syndrome. While bisphosphonates can be a valuable tool for some horses, the study emphasizes the need for careful monitoring and consideration of potential side effects.
Understanding the Risks and Benefits: A Balanced Approach
As a veterinarian or horse owner, this study provides critical information for making informed decisions regarding the use of bisphosphonates in horses. Understanding the potential benefits and risks associated with this treatment approach is crucial for providing optimal care for our equine companions.
Dr. Camel's Conclusion
Just like a wise camel knows how to navigate the desert, we must approach the use of bisphosphonates in horses with caution and care. This study offers valuable insight into the potential benefits and risks of this treatment approach, reminding us that a balanced perspective is essential for providing the best possible care for our equine partners.
Date :
- Date Completed 2019-01-02
- Date Revised 2019-01-02
Further Info :
Related Literature
German
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.